Literature DB >> 2405950

Pharmacokinetics in old age.

B F Tregaskis1, L H Stevenson.   

Abstract

All practising clinicians will be aware of the increased number of elderly patients requiring drug treatment as the proportion of people over the age of 65 increases in our Western society. The elderly as a group have much to benefit from modern drug therapy, but, historically, are also the group most prone to adverse drug reactions. Such reactions have often been due to inappropriate drug prescribing based on an incomplete knowledge of changes in drug handling with age. In recent years there has been an increased understanding of the physiological changes of ageing and the changes in drug handling consequent upon these changes. This review will concentrate on the clinical sequelae of changes in drug handling and suggest areas where modification in prescribing practice may yield clinical benefits and lessen the toll of adverse drug reactions.

Entities:  

Mesh:

Year:  1990        PMID: 2405950     DOI: 10.1093/oxfordjournals.bmb.a072397

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  3 in total

Review 1.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

2.  The influence of ageing on cisplatin pharmacokinetics in lung cancer patients with normal organ function.

Authors:  N Yamamoto; T Tamura; M Maeda; M Ando; T Shinkai; K Eguchi; Y Ohe; F Oshita; J Shiraishi; N Katsumata
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 3.  Mechanisms and management of stroke in the elderly.

Authors:  A Shuaib; V C Hachinski
Journal:  CMAJ       Date:  1991-09-01       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.